Peter Salzmann, Chief Executive Officer at Immunovant, Inc. (IMVT), sold 206,116 shares at $21.34 ($4.4M) on 2023-08-14, disclosed to the SEC on 2023-08-16.
Open-market sale of $4.4M IMVT by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $21.34 | 91,744 | $2.0M | 44.4% |
| 2 | $21.34 | 91,744 | $2.0M | 44.4% |
| 3 | $22.04 | 11,314 | $249K | 5.6% |
| 4 | $22.04 | 11,314 | $249K | 5.6% |
| Total | $21.42 avg | 206,116 | $4.4M | 100% |
| Filing → |
| IMVT | SELL | 2025-02-21 | $644K | — | Filing → |
| IMVT | SELL | 2025-01-17 | $408K | — | Filing → |
| IMVT | SELL | 2025-01-10 | $246K | — | Filing → |